Start: October 1, 2019
End: October 2021
Enrollment: 96
This study is designed to combine the effects of physical exercise and cognitive training to improve cognition and reduce the risk of Alzheimer's disease (AD). The Phase 2 randomized controlled trial (RCT) will test the effects of Exergame, a combination of virtual reality cognitive training games and stationary bicycle cycling, on cognition, aerobic fitness, and physical function in persons with subjective cognitive decline at risk for developing AD. Participants will be randomly assigned to one of three study groups and participate three times per week for 12 weeks.
Minimum Age: 65 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Minnesota | |
---|---|
University of Minnesota
Minneapolis, MN 55455
Recruiting
Russell L Spafford, MS |
Lead: Moai Technologies LLC
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT04311736
An official website of the U.S. government, managed by the National Institutes on Aging at the National Institutes of Health